Journal
CURRENT PSYCHIATRY REPORTS
Volume 14, Issue 4, Pages 289-297Publisher
SPRINGER
DOI: 10.1007/s11920-012-0281-z
Keywords
Depression; Aging; Older adults; Comorbidity; Polypharmacy; Antidepressants; Tricyclic antidepressants; Selective serotonin reuptake inhibitors; Serotonin and norepinephrine reuptake inhibitors; Monoamine oxidase inhibitors; Adverse effects; Treatment; Resistance to treatment; Recovery; Electroconvulsive therapy; Transcranial magnetic stimulation; Integrated psychotherapy
Categories
Ask authors/readers for more resources
Depression is the most frequent mental disorder in older people, often causing emotional distress and reduced quality of life. Despite its clinical significance, depression remains underdiagnosed and inadequately treated in older patients. Regarding prognosis, data suggest that almost 70% of patients, treated long enough and with appropriate doses, recover from an index episode of depression. Antidepressants are efficient for treating depressed outpatients with several comorbid physical diseases as well as hospitalized patients, with selective serotonin reuptake inhibitors being the antidepressants of choice for older patients. Available data can guide pharmacological treatment in both the acute and maintenance stages, but further research is required to guide clinical strategies when remission is not achieved. Approaches for the management of resistance to treatment are summarized, including optimization strategies, drug changes, algorithms, and combined and augmentation pharmacological treatments. Finally, additional therapeutic choices such as electroconvulsive therapy, transcranial magnetic stimulation, and integrated psychotherapy are presented.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available